Demant upgrades outlook and Oddo targets Demant stock at DKK 275
Published on 10/13/2026 at 00:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Demant upgraded its 2026 organic-growth outlook to 7-8 percent and resumed share buybacks.
- The company expects 2026 EBIT before special items of DKK 4.7-5.0 billion.
- Demant was last at DKK 350.80 on Nasdaq Copenhagen on October 12, 2026.
- The next Interim Management Statement is scheduled for November 3, 2026.
Demant A/S upgraded its 2026 outlook to 7-8 percent organic growth from 6-7 percent and resumed a share buyback worth at least DKK 3 billion by the end of 2027. According to Finanznachrichten on October 9, 2026, EBIT before special items is now expected at DKK 4,700-5,000 million, versus DKK 4,400-4,800 million previously.
Third-quarter growth sets the tone
The upgrade followed preliminary third-quarter figures showing group organic growth of 11 percent. Hearing Aids delivered 17 percent organic growth, while total group revenue reached DKK 6,624 million compared with DKK 5,454 million in the third quarter of 2025, according to Finanznachrichten.
The product launch of Oticon Reveal was identified as a key contributor to the hearing-aid performance, particularly in the US commercial market. Demant also said the launch improved product mix and average selling price in the third quarter, while competition remained part of the 2026 outlook.
Chronology brings the revisions together
On August 13, 2026, Goldman Sachs raised its Demant target to DKK 330 from DKK 290 and reiterated Buy, as reported by MarketScreener. On September 18, 2026, Oddo raised its target to DKK 275 from DKK 260 and kept Neutral, according to MarketScreener. On October 9, 2026, Demant upgraded its outlook and resumed buybacks through 2027, according to Finanznachrichten.
What the buyback means for margins
The margin signal is the DKK 4.7-5.0 billion EBIT range for 2026. Demant linked the capital return decision to cash-flow development and said it expects gearing to finish 2027 within a target range of 2.0-2.5 times.
Next reporting date is November 3
Demant said its full Interim Management Statement for the third quarter of 2026 will be published on November 3, 2026 after 5:00 p.m. CET, according to Finanznachrichten. The date will provide the next fuller test of whether the Oticon Reveal launch can sustain the third-quarter growth rate.
Nasdaq Copenhagen context
Demant was last at DKK 350.80 on Nasdaq Copenhagen on October 12, 2026 at 4:59 p.m. CEST. Market capitalization stood at DKK 74.0 billion on October 12, 2026, while the year range was DKK 175.00 to DKK 353.80.
The further course of trading is shown by the continuously updated real-time quote of Demant stock.
Demant stock facts
- Company: Demant A/S
- ISIN: DK0060738599
- Ticker: DEMANT.CO
- Primary exchange: Nasdaq Copenhagen
- Market capitalization: DKK 74.0 billion (as of October 12, 2026)
- 52-week range: DKK 175.00-353.80 (as of October 12, 2026)
- Sector / Industry: Health Care / Medical Equipment, Supplies and Distribution
- Index membership: OMX Copenhagen 25
- Next earnings date: November 3, 2026
Market context: Latest market reports.
